Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (451-460 of 607) with videos related to

Pageof 61
Sort By:
European Journal of Heart Failure|March 20, 2014
The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequencesIjsbrand T Klip, Ewa A Jankowska, Cristina Enjuanes, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 23, 2018
Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot StudyMarina Navarro-Peñalver, M Teresa Perez-Martinez, Manuel Gómez-Bueno, et al.
Open Heart|April 17, 2026
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in CataloniaBenjamin Casteigt, Emili Vela, Ermengol Valles, et al.
European Journal of Preventive Cardiology|May 10, 2021
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrantsPriyanka Satish, Emili Vela, Usama Bilal, et al.
ESC Heart Failure|November 1, 2018
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge periodGerhard Pölzl, Shadab Allipour Birgani, Josep Comín-Colet, et al.
European Journal of Heart Failure|June 22, 2013
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trialGerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, et al.
European Journal of Heart Failure|October 13, 2018
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practiceTheresa McDonagh, Thibaud Damy, Wolfram Doehner, et al.
Journal of Personalized Medicine|March 29, 2023
Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection FractionHelena Cristóbal, Cristina Enjuanes, Montserrat Batlle, et al.
European Journal of Internal Medicine|May 23, 2020
Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidenceJosé Gonzalez-Costello, Miguel Cainzos-Achirica, Josep Lupón, et al.
European Heart Journal|September 2, 2014
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†Piotr Ponikowski, Dirk J van Veldhuisen, Josep Comin-Colet, et al.
Pageof 61

Showing results (451-460 of 607) with videos related to

Sort By:
Pageof 61
European Journal of Heart Failure|March 20, 2014
The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequencesIjsbrand T Klip, Ewa A Jankowska, Cristina Enjuanes, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 23, 2018
Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot StudyMarina Navarro-Peñalver, M Teresa Perez-Martinez, Manuel Gómez-Bueno, et al.
Open Heart|April 17, 2026
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in CataloniaBenjamin Casteigt, Emili Vela, Ermengol Valles, et al.
European Journal of Preventive Cardiology|May 10, 2021
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrantsPriyanka Satish, Emili Vela, Usama Bilal, et al.
ESC Heart Failure|November 1, 2018
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge periodGerhard Pölzl, Shadab Allipour Birgani, Josep Comín-Colet, et al.
European Journal of Heart Failure|June 22, 2013
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trialGerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, et al.
European Journal of Heart Failure|October 13, 2018
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practiceTheresa McDonagh, Thibaud Damy, Wolfram Doehner, et al.
Journal of Personalized Medicine|March 29, 2023
Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection FractionHelena Cristóbal, Cristina Enjuanes, Montserrat Batlle, et al.
European Journal of Internal Medicine|May 23, 2020
Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidenceJosé Gonzalez-Costello, Miguel Cainzos-Achirica, Josep Lupón, et al.
European Heart Journal|September 2, 2014
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†Piotr Ponikowski, Dirk J van Veldhuisen, Josep Comin-Colet, et al.
Pageof 61